PEDIATRICS Vol. 71 No. 4 April 1983, pp. 510-514
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shapiro, G. G.
Right arrow Articles by Bierman, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shapiro, G. G.
Right arrow Articles by Bierman, C. W.

Double-Blind Evaluation of Methylprednisolone Versus Placebo for Acute Asthma Episodes

Gail G. Shapiro MD1, Clifton T. Furukawa MD1, William E. Pierson MD1, Rhonda Gardinier BS1, and C. Warren Bierman MD1

1 From the Division of Allergy, Children's Orthopedic Hospital and Medical Center, Seattle

Twenty-eight children with persistent bronchospasm after outpatient therapy were treated for eight days with methylprednisolone or placebo in a prerandomized double-blind manner, in addition to treatment with optimal oral bronchodilators. At follow-up visits 1, 7, and 14 days after onset of therapy, a history was taken and physical examination and pulmonary function tests were performed. Initially and on the 14th day, patients underwent cosyntropin tests of adrenal function. Patients kept daily peak flow charts. Both groups improved with time. However, by 24 hours after starting methylprednisolone therapy, the placebo group continued to show reversibility after isoproterenol inhalation whereas the methylprednisolone group did not. By day 7 there were significantly more patients with normal 1-second forced expiratory volume (FEV1) and forced expiratory flow in the middle half of the forced vital capacity (FEF25-75%) in the methylprednisolone group and mean FEF25-75% was significantly higher for this group (P < .02). By day 14, six days after finishing treatment with the study drugs, more patients in the placebo group had residual wheezing, but pulmonary function tests were now similar for the two groups. Although both groups showed a decline in cosyntropin responsiveness on day 14 compared with day 1, there was no difference between the steroid- and placebo-treated patients. This study proves that short-term corticosteroid therapy will accelerate resolution of moderately severe and severe-acute attacks of asthma without significant suppression of adrenal function.

Key Words: asthma • steroids • methylprednisolone

Submitted on May 7, 1982
Accepted on July 20, 1982




This article has been cited by other articles:


Home page
 PediatricsHome page
S. Schuh, P. T. Dick, D. Stephens, M. Hartley, S. Khaikin, L. Rodrigues, and A. L. Coates
High-Dose Inhaled Fluticasone Does Not Replace Oral Prednisolone in Children With Mild to Moderate Acute Asthma
Pediatrics, August 1, 2006; 118(2): 644 - 650.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. R. McFadden Jr.
Acute Severe Asthma
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
G. Rachelefsky
Treating Exacerbations of Asthma in Children: The Role of Systemic Corticosteroids
Pediatrics, August 1, 2003; 112(2): 382 - 397.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Schuh, J. Reisman, M. Alshehri, A. Dupuis, M. Corey, R. Arseneault, G. Alothman, O. Tennis, and G. Canny
A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma
N. Engl. J. Med., September 7, 2000; 343(10): 689 - 694.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. H. Rowe, G. W. Bota, L. Fabris, S. A. Therrien, R. A. Milner, and J. Jacono
Inhaled Budesonide in Addition to Oral Corticosteroids to Prevent Asthma Relapse Following Discharge From the Emergency Department: A Randomized Controlled Trial
JAMA, June 9, 1999; 281(22): 2119 - 2126.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
S. Press and R. S. Lipkind
A Treatment Protocol of the Acute Asthma Patient in a Pediatric Emergency Department
Clinical Pediatrics, October 1, 1991; 30(10): 573 - 577.
[Abstract] [PDF]